Actively Recruiting
Comparing Propranolol and Ivabradine for Treating Postural Tachycardia Syndrome in Adults Aged 18 to 60
Led by University of Calgary · Updated on 2024-05-09
20
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Postural tachycardia syndrome POTS is a condition causing symptoms like palpitations, lightheadedness, chest discomfort, shortness of breath, blurred vision, and mental clouding upon standing due to a rapid increase in heart rate without low blood pressure. POTS significantly reduces quality of life and daily functioning. This trial evaluates and compares the effects of two drugs, propranolol and ivabradine, on heart rate response to standing and symptom burden in POTS patients through a randomized crossover design. Participants will undergo three separate 4-week treatment periods with oral ivabradine, propranolol, or placebo, separated by 7-day washout phases. Ivabradine is given as 5 mg twice daily plus placebo twice daily to match a four-times-daily schedule, propranolol as 10 mg four times daily, and placebo as four times daily. Each participant receives all three treatments in random order, acting as their own control. The study includes baseline screening and assessments after each treatment phase. Throughout the study, participants attend four visits for testing including tilt table exams to measure heart rate changes during head-up tilt, neuropsychological testing for memory and attention, and continuous monitoring of blood pressure and electrocardiogram. They also complete symptom and quality of life questionnaires. After each visit, a 24-hour heart rhythm monitor is worn. The entire trial involves close monitoring of heart rate changes and symptom evaluation over several months.
CONDITIONS
Brief Title
Crossover Study of Propranolol vs Ivabradine in POTS
Research Team
S
Satish Raj, MD
S
Shahana Safdar
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here